| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 08/17/1994 | EP0530268B1 Process for the preparation of 7-alpha-alkoxycephem derivatives |
| 08/17/1994 | EP0527720B1 Therapeutic agents |
| 08/17/1994 | CN1090849A Arylidene-1-azacycloalkanes and arylalkyl-1-azacycloalkanes, their salts, medicaments containing these compounds and .... |
| 08/17/1994 | CN1090776A Method for the safe administration of fatty acids |
| 08/17/1994 | CN1090757A Method for the safe administration of fatty acids |
| 08/17/1994 | CN1025676C Non-peptidic renin inhibitors |
| 08/17/1994 | CA2115737A1 Condensed 5-membered heterocyclic compounds, processes for preparing them and pharmaceutical compositions containing these compounds |
| 08/16/1994 | US5338851 Synthesis of cis-decahydroisoquinoline-3-carboxylic acids |
| 08/16/1994 | US5338849 Azaindoles, preparation processes and medicinal products containing them |
| 08/16/1994 | US5338840 DNA encoding glioma-derived growth factor having vascular endothelial cell growth promoting activity |
| 08/16/1994 | US5338760 Treatment of nervous system and gastrointestinal disorders |
| 08/16/1994 | US5338744 Angiotensin II antagonists used to treat reproductive functions associated with AT2 receptors |
| 08/16/1994 | US5338735 Pharmaceutical compounds |
| 08/16/1994 | US5338734 Heterocyclic amide derivatives and pharmaceutical use thereof |
| 08/16/1994 | US5338549 Powdered psyllium drink mix compositions containing antioxidant |
| 08/16/1994 | CA2115630A1 Bioactive conjugates of cellulose with amino compounds |
| 08/10/1994 | EP0609963A1 Use of benzimidazoles and benzotriazoles in the treatment of epithelial disorders |
| 08/10/1994 | EP0609960A1 New N-heteroarylamide derivatives as inhibitors of acyl coenzyme A: cholestrol acyl transferase |
| 08/10/1994 | EP0609901A1 T-cell receptor-specific for antigen polypeptides and related polynucleotides |
| 08/10/1994 | EP0609739A1 Method of reversing immunosuppression in vaccines |
| 08/10/1994 | EP0609722A1 An in vitro method for detecting the presence of invasive stimuli in mammals |
| 08/10/1994 | EP0609701A1 L-cystein, L-cystine or L-glutamine as a supplementary therapeutic agent for the treatment of immunodeficiency syndrome |
| 08/10/1994 | EP0609625A1 Inhibitors of HIV protease useful for the treatment of AIDS |
| 08/10/1994 | EP0609310A1 N-(mercaptoacyl)amino acids, methods of their preparation and therapeutic use, and pharmaceutical compositions containing them |
| 08/10/1994 | EP0609278A1 Imidazopyridines and indolizines as 5-ht 4 antagonists |
| 08/10/1994 | EP0564561A4 Peptides ketoamides, ketoacids, and ketoesters |
| 08/10/1994 | EP0533739B1 Injectable pharmaceutical composition |
| 08/10/1994 | CN1090490A Fatty acid treatment |
| 08/10/1994 | CN1025619C Research scientist II/cardio-vascular chemistry |
| 08/10/1994 | CA2115221A1 Aminomethylene-peptides as immunosuppressants |
| 08/09/1994 | US5336783 Calpain inhibitor cystamidin A and its production |
| 08/09/1994 | US5336778 Substituted triazoles as angiotensin II antagonists |
| 08/09/1994 | US5336690 Anticholesterol agents |
| 08/09/1994 | US5336677 Substituted aminopyrimidines as antihypertensives |
| 08/09/1994 | US5336675 Administering acetylcholinesterase inhibitor which can pass through blood-brain barrier in humans |
| 08/09/1994 | US5336496 Inhibitor for delta 5-desaturase |
| 08/09/1994 | CA1331419C Peptides with pharmaceutical activity |
| 08/09/1994 | CA1331356C Mutant human angiogenin (angiogenesis factor with superior angiogenin activity) genes therefor and methods of expression |
| 08/06/1994 | CA2113913A1 Acetanilide derivatives |
| 08/04/1994 | WO1994017100A1 Icam-related protein |
| 08/04/1994 | WO1994017099A2 BIOLOGICALLY ACTIVE TGF-β1 AND TGF-β2 PEPTIDES |
| 08/04/1994 | WO1994017091A2 Foldback triplex-forming oligonucleotides |
| 08/04/1994 | WO1994017076A1 Condensed heterocyclic glutamic acid derivatives as antiproliferative agents |
| 08/04/1994 | WO1994017061A1 Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides |
| 08/04/1994 | WO1994017045A1 Spiro-substituted azacycles as tachykinin receptor antagonists |
| 08/04/1994 | WO1994017040A1 Diarylalkyl piperidines useful as multi-drug resistant tumor agents |
| 08/04/1994 | WO1994017035A1 Aminoacid derivates, medicaments containing these compounds and process for preparing the same |
| 08/04/1994 | WO1994017034A1 Substituted amino compounds, their preparation and their use as inhibitors of thrombocyte aggregation |
| 08/04/1994 | WO1994016724A1 Prevention and treatment of cytomegalovirus using aminopeptidase |
| 08/04/1994 | WO1994016723A2 Wound healing composition |
| 08/04/1994 | WO1994016697A1 Synergising association having an antagonist effect on nk1 and nk2 receptors |
| 08/04/1994 | WO1994016690A1 Method for increasing the efficiency of feed conversion in animals |
| 08/04/1994 | WO1994013808A3 LYMPHOTOXIN-β, LYMPHOTOXIN-β COMPLEXES, PHARMACEUTICAL PREPARATIONS AND THERAPEUTIC USES THEREOF |
| 08/04/1994 | WO1994011377A3 Water soluble camptothecin derivatives |
| 08/04/1994 | CA2154569A1 Spiro-substituted azacycles as tachykinin receptor antagonists |
| 08/04/1994 | CA2154358A1 Integrated oligonucleotides |
| 08/04/1994 | CA2154346A1 Prevention and treatment of cytomegalovirus using aminopeptidase |
| 08/04/1994 | CA2154078A1 Wound healing composition |
| 08/04/1994 | CA2153582A1 Amino acid derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
| 08/04/1994 | CA2132637A1 Icam-related protein |
| 08/03/1994 | EP0609064A1 Use of fatty acids for treatment of internal radiation damage |
| 08/03/1994 | EP0608893A1 Inhibiting the development of tolerance to and/or dependence on an additive substance |
| 08/03/1994 | EP0608847A1 Carbocyclic sulfonamides as agonists or antagonists of PGEZ |
| 08/03/1994 | EP0608759A2 Piperazinderivatives |
| 08/03/1994 | EP0608709A1 2-Oxo-quinolin-1-yl-methyl-phenylacetic acid derivatives as angiotensin II Antagonists |
| 08/03/1994 | EP0608671A1 Use of 3-indolepyruvic acid to reduce the level of glucocorticoids in the blood and to prevent cerebral disturbances |
| 08/03/1994 | EP0608336A1 Azabicyclo arylacetylene and arylenyne oximes as cholinergic agents and methods of treatment |
| 08/03/1994 | EP0608313A1 Formulations of blood clot-polymer matrix for delivery of osteogenic proteins |
| 08/03/1994 | EP0572425B1 Imidazopyridine paf/h 1 antagonists |
| 08/03/1994 | EP0454831B1 Diazine derivatives as angiotensin II receptor antagonists |
| 08/03/1994 | EP0419534B1 Wound healing |
| 08/03/1994 | CN1090289A Calcium channel blocking polypeptides from theraphosidae aphonopelma |
| 08/03/1994 | CN1090286A Chelans possessing ortho ligating functionality and complexes thereof |
| 08/03/1994 | CN1090282A Sulfonamide derivatives of benzenefused, hydroxy substituted cycloalkyl and heterocyclic ring compound |
| 08/03/1994 | CN1090278A Renin Inhibiting N-(2-Amino-2-oxoethyl)-butanediamide derivatives |
| 08/03/1994 | CN1090277A Benzoxazinones as inhibitors of HIV reverse transcriptase |
| 08/03/1994 | CN1090272A New substituted azetidinones as anti-inflammatory and antidegenerative agents |
| 08/03/1994 | CN1090201A Angiotensin converting enzyme inhibitor and method for preparing same |
| 08/03/1994 | CN1025564C Leukotriene antagonists |
| 08/03/1994 | CN1025563C A process for preparing an indan derivative |
| 08/03/1994 | CA2114611A1 Method of reversing immunosuppression in vaccines |
| 08/02/1994 | US5334767 Benzo[F]quinolinones |
| 08/02/1994 | US5334716 Preventing testosteron 5a-reductase mediated diseases; alopecia, acne, prostatism |
| 08/02/1994 | US5334711 Synthetic catalytic oligonucleotide structures |
| 08/02/1994 | US5334618 Administering amantadine or derivative |
| 08/02/1994 | US5334614 Lipoxygenase inhibitor |
| 08/02/1994 | US5334594 Antihistamines, antiallergens |
| 08/02/1994 | US5334511 Microorganism escherichia contains recombiant DNA, culturing |
| 08/02/1994 | US5334375 Antibacterial antiplaque oral composition |
| 08/02/1994 | US5334138 Drug delivery; mixture of active material and vasoconstrictor |
| 08/02/1994 | CA1331196C Use of retinoids |
| 08/02/1994 | CA1331191C Therapeutically useful tetralin derivatives |
| 08/02/1994 | CA1331140C Agents for preserving or restoring the soundness of the skin |
| 08/02/1994 | CA1331132C Method of treatment for non-specific inflammation |
| 08/02/1994 | CA1331131C Cyclic peptides as promoters of absorption on administration onto the mucosa |
| 07/30/1994 | CA2114361A1 Piperazine derivatives |
| 07/30/1994 | CA2113787A1 Carbocyclic sulfonamides |
| 07/27/1994 | EP0607777A2 Use of leflunomid for the inhibition of interleukin 8 |
| 07/27/1994 | EP0607776A2 Use of leflunomid for the inhibition of tumor necrosis factor alpha |
| 07/27/1994 | EP0607775A2 Use of leflunomid for the inhibition of interleukin 1 beta |